Katin samfurin da aka shigar a ranar 10 ga Janairu ya haɗu da fiye da 600 irin wannan da'awar da aka haɗa a cikin shari'ar multidistrict (MDL) a cikin kotun tarayya ta New Jersey a madadin marasa lafiya waɗanda suka sami lalacewar retina da matsalolin hangen nesa bayan amfani da Elmiron don maganin cystitis na tsakiya, wanda ke haifar da mafitsara na kullum. zafi.
"J&J da Janssen sun kalli wata hanya lokacin da rahotanni suka fara shigowa game da haɗarin Elmiron," in ji lauyan shari'ar Houston Mark Lanier, wanda ya kafa Lanier Law Firm, wanda ke aiki a kwamitin zartarwa na Elmiron MDL. "Muna sa ran neman alkali da ya dauki nauyin kamfanin da kuma tabbatar da cewa wani abu makamancin haka bai sake faruwa ba."
A cewar karar, Janssen ya san rahotannin jim kadan bayan Elmiron ya tafi kasuwa a cikin 1996. Nazarin asibiti da aka fara a cikin 2018 ya rubuta alaƙa tsakanin mahimman abubuwan Elmiron, pentosan polysulfate sodium ko PPS, da yanayin da aka sani da maculopathy pigmentary. Duk da haka ba a sanya alamar gargadi akan maganin ba har sai 2020.
PPS shine kadai sanannen sanadin maculopathy na pigmentary, wanda galibi ana yin kuskure a matsayin lalacewar macular degeneration na shekaru ko dystrophy alamu. Abubuwan da ke haifar da illa sun haɗa da tabo masu duhu a cikin filin hangen nesa, wahalar karantawa ko daidaitawa zuwa haske mai duhu, asarar hangen nesa, dagewar ido yayin karatu da sauran ayyukan, duhun gani da makanta.
Raunin da Beverly Frizzell ya samu ya kasance "mai yiwuwa ne kuma ya haifar da kai tsaye daga gazawar waɗanda ake tuhuma da ƙin gudanar da ingantaccen nazarin tsaro, gazawar tantancewa da kuma bayyana siginar aminci, danne bayanan da ke bayyana haɗarin haɗari, ganganci da rashin son rai don samar da isassun umarni, da kuma ba da gangan ba game da yanayi da amincin Elmiron,” in ji karar.
Shari'ar tana cikin Re: Elmiron MDL No. 2973.